Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice

ConclusionsStereotactic body radiotherapy for early prostate cancer reported safe toxicity profile and a good clinical outcome at the median follow-up of 5  years. It may be an useful option if radiotherapy is required in emergency medical conditions.
Source: La Radiologia Medica - Category: Radiology Source Type: research